Walmart Extends Use of the Inovalon ONE® Platform

Retailer Extends Relationship with Inovalon to 2028

BOWIE, Md. – June 24, 2021 – Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced an expansion and extension of the long-term engagement with Walmart (NYSE: WMT) to provide cloud-based capabilities through the Inovalon ONE® Platform in its extensive network of pharmacies nationwide as part of its data-driven strategy to improve outcomes and economics for its customers.

Under the agreement, Walmart will extend its engagement into 2028 and will look to expand its use of Inovalon’s cloud-based capabilities through the Inovalon ONE® Platform by extending the use of ScriptMed Specialty to empower the clinical care management of complex patient populations served by Walmart’s extensive nationwide network of retail pharmacies and to add additional advanced Inovalon ONE® Platform functionality.

The broader Inovalon and Walmart engagement was initiated in 2020 with the implementation of Inovalon’s ScriptMed Specialty offering, a configuration of the Inovalon ONE® Platform designed to combine analytically driven care protocols with superior quality, operational processes, and cost efficiencies.

“We are committed to a patient-centric approach to dispensing medicine that makes it easy, convenient and fast for our customers to get the medications they need to improve their health,” said Mike Adloo, senior director of Health & Wellness, Walmart.

“Walmart has an impressive track record of innovative approaches to serving their customers, which is providing measurable value to the marketplace,” said Keith Dunleavy, M.D., chief executive officer of Inovalon. “We are honored to work with Walmart and are eager to further contribute to their mission of delivering quality care with the Inovalon ONE® Platform.”

About Inovalon
Inovalon is a leading provider of data and solutions empowering data-driven healthcare. We bring together national-scale connectivity, real-time primary source data access, and advanced analytics into a sophisticated platform empowering improved outcomes and economics across the healthcare ecosystem. The company’s analytics and capabilities are used by over 50,000 active, licensed customers, and are informed by the primary source data of more than 99 billion medical, pharmacy, and lab events across 1.1 million clinicians, 736,000 clinical settings, and 461 million unique lives. For more information, visit www.inovalon.com.

Contact:

Glen Brandow
Sr. Director, Communications, Inovalon
Glen.Brandow@inovalon.com